Skip to main content

Table 4 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-C30 scores of patients with chronic obstructive pulmonary disease (COPD) according to airway obstruction

From: Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer

Variables GOLD grade 1
(n = 35)
GOLD grade 2
(n = 103)
GOLD grade 3
(n = 24)
GOLD grade 4
(n = 8)
p value
Global health status/QoL 50.5 ± 26.3 50.2 ± 23.0 41.0 ± 19.0 30.2 ± 26.7 0.049
Functional scales
 Physical functioning 83.4 ± 17.1 75.4 ± 22.7 66.7 ± 24.4 53.3 ± 30.4 0.004
 Role functioning 79.5 ± 31.3 75.9 ± 24.2 69.4 ± 33.9 54.2 ± 39.6 0.132
 Emotional functioning 75.0 ± 26.2 76.4 ± 25.0 78.5 ± 21.8 70.8 ± 32.1 0.970
 Cognitive functioning 87.1 ± 21.4 79.0 ± 25.1 77.8 ± 22.3 75.0 ± 21.8 0.123
 Social functioning 72.4 ± 28.9 68.1 ± 26.4 68.1 ± 26.4 60.4 ± 33.3 0.646
Symptom scales/items
 Fatigue 25.1 ± 24.6 34.5 ± 22.8 40.7 ± 24.7 47.2 ± 31.3 0.011
 Nausea and vomiting 9.5 ± 23.3 9.2 ± 15.8 1.4 ± 4.7 8.3 ± 23.6 0.059
 Pain 18.6 ± 30.2 22.0 ± 26.8 20.1 ± 26.5 25.0 ± 38.8 0.622
 Dyspnea 20.0 ± 24.5 33.7 ± 31.8 44.4 ± 36.3 54.2 ± 35.4 0.010
 Insomnia 24.8 ± 31.7 27.2 ± 29.4 36.1 ± 31.0 37.5 ± 37.5 0.352
 Appetite loss 27.6 ± 36.6 30.4 ± 32.0 31.9 ± 36.1 45.8 ± 43.4 0.621
 Constipation 14.3 ± 24.6 16.2 ± 26.8 19.4 ± 31.0 41.7 ± 49.6 0.435
 Diarrhea 7.6 ± 18.2 7.8 ± 20.5 6.9 ± 17.0 4.2 ± 11.8 0.988
 Financial difficulties 25.7 ± 31.4 32.7 ± 29.9 40.3 ± 34.0 37.5 ± 33.0 0.320
  1. Data are mean (±SD). GOLD Global Initiative for Chronic Obstructive Lung Disease, QoL quality of life
  2. ANOVA test was used